MeSH tree: C04.588.805
Researchers from the Johns Hopkins Kimmel Cancer Center and The Johns Hopkins University have created a novel database structure that allows investigators anywhere to more easily study multiple types of cancer data—including ...
Mar 4, 2026
0
0
A long-running Queensland study has found children today are developing significantly fewer moles than kids 25 years ago, with predictions of a major reduction in future melanoma risk. The Brisbane Twin Nevus Study, led by ...
Mar 4, 2026
0
0
Pro-inflammatory M1 macrophages involved in immune responses accelerate the progression of melanoma through the extracellular vesicles they secrete, a study from the University of Eastern Finland shows. The findings are published ...
Mar 3, 2026
0
0
It's an increasingly common scenario. You fill in an online form to request an appointment with a doctor, and back comes a link asking you to upload a photo of your ailment. You pick up your phone, a couple of clicks and ...
Feb 28, 2026
0
0
For patients with advanced melanoma without BRAF mutation who no longer respond to immune checkpoint inhibitors, treatment options remain frustratingly limited. A new study from Vanderbilt researchers led by Professor Emerita ...
Feb 27, 2026
0
0
Consumers can protect their skin from damaging ultraviolet (UV) light rays for as little as $40 a year—or as much as $1,400 a year—depending on how expensive a sunscreen they buy and how much of their skin they protect ...
Feb 26, 2026
0
0
An autoimmune disorder that affects the thyroid gland, called autoimmune hypothyroidism (AIHT), is the most common autoimmune disease, yet it remains largely understudied. New research from scientists at Broad Institute, ...
Feb 26, 2026
0
2
Douglas Grossman, MD, Ph.D., co-leader of the Melanoma Center at Huntsman Cancer Institute at the University of Utah (the U) and professor of dermatology at the U, has helped develop a noninvasive technology that aims to ...
Feb 25, 2026
0
0
Immunotherapy given before or after surgery is increasingly used across several cancer areas. In an article published in the Journal of Internal Medicine, researchers at Karolinska Institutet present a comprehensive review ...
Feb 16, 2026
0
0
Seventy-five percent of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN) who were treated with the antibody-drug conjugate (ADC) pivekimab sunirine (PVEK) had a complete response, according to new data from ...
Feb 12, 2026
0
0
